Over 60 global pharmaceutical companies, large and small, rely on Abveris to develop therapeutic antibody candidates.
Our Boston-based team of discovery scientists is composed of experienced biotherapeutic drug discovery scientists with a passion for novel antibody discovery. We use advanced immunization techniques, engineered in vivo systems, optimized antibody capture methods, robust high-throughput screening technologies, and diverse ancillary capabilities to deliver excellent therapeutic leads with critical timelines in mind.
We like to meet in person with our Boston clients. We can setup a Zoom to connect if you're further away.
Subscribe here for quarterly updates on new service offerings, case studies, and press releases. We'll never share your contact information externally.
Click here to join our mailing list.